Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital
   
Cancer Resource Room

Learn About Cancer

Find Your Cancer Type


 

Learn About Living
with Cancer

Cancer Topics

 


Contact Us

Locations & Hours

 

 

Hematological Cancers

Source: Cancer Resource Room

Hematologic means "of the blood system." These cancers usually affect the white blood cells (disease and infection-fighting cells) rather than the red blood cells (oxygen-carrying cells). Some of these cancers are in the marrow where all blood cells are made. Some are in the lymph nodes and other lymph tissues that the white blood cells flow through. Common cancers of the white blood cells are:

Leukemias
Leukemia is a cancer of the bone marrow. This cancer of the marrow makes too many white blood cells. To read more about Leukemias >>>

Lymphomas- Hodgkins & Non-Hodgkins
Lymphomas are cancers of the cells and tissues of the body’s defense (immune) system. Most lymphomas start in the lymph nodes which get bigger as the cancer cells multiply (commonly known as “swollen glands”). Two types of lymphomas will be discussed:
To read more on Lymphoma Basics >>>
To read more on Hodgkin's Disease >>>
To read more on Non-Hodgkin's Lymphoma >>>

Multiple Myeloma
Myeloma is a cancer of the white blood cells of the bone marrow. The white blood cells are the infection-fighting cells of the body. To read more on Multiple Myeloma >>>

Other Blood Cancers - Myeloproliferative Disorders & Myelodysplastic Syndrome
Myelodysplastic/myeloproliferative diseases (MDS/MPD) are diseases of the bone marrow that have shared characteristics of both myeloproliferative disorders and myelodysplastic syndromes. To read more about Other Blood Cancers >>>

What’s New Hematological Cancers?

Presently, only 25% of people who need a bone marrow transplant have a compatible sibling donor. We are in the process of evaluating strategies for mismatched stem cell transplantation that, if are successful, will mean virtually every patient who needs a donor will have one. With our tolerance induction strategies, transplant recipients can be freed from a lifelong regimen of powerful immunosuppressive drugs.

To Search Pub Med on hematological cancers, please see below.
Consumer Journals
Selected Professional Journals